Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Journal of Inherited Metabolic Disease|October 23, 2024
Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapyChristoph Kampmann, Christina Lampe, Christiane M Wiethoff, et al.Fortschritte Der Neurologie-Psychiatrie|February 9, 2021
[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]Andreas Hahn, Christina Lampe, Matthias Boentert, et al.Orphanet Journal of Rare Diseases|August 27, 2016
Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issuesChristian J Hendriksz, Kenneth I Berger, Christina Lampe, et al.Journal of Inherited Metabolic Disease|December 1, 2011
Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)Christian J Hendriksz, Roberto Giugliani, Paul Harmatz, et al.Journal of Inherited Metabolic Disease|March 6, 2014
Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case seriesChristina Lampe, Ann-Kathrin Bosserhoff, Barbara K Burton, et al.BMC Health Services Research|June 6, 2026
An international observational study on transition of care from paediatric to adult services for patients with mucopolysaccharidosis IIKarolina M Stepien, Olulade Ayodele, Joseph Muenzer, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 4, 2010
Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome SurveyNancy J Mendelsohn, Paul Harmatz, Olaf Bodamer, et al.Frontiers in Endocrinology|February 23, 2026
Automated bone age assessment in rare pediatric growth disorders: a comparative study using DeeplasiaKyra Skaf, Minu Fardipour, Philipp Schmidt, et al.Molecular Genetics and Metabolism|June 25, 2016
Cervical cord compression in mucopolysaccharidosis VI (MPS VI): Findings from the MPS VI Clinical Surveillance Program (CSP)Guirish A Solanki, Peter P Sun, Kenneth W Martin, et al.Pageof 7